ITRM20020255A1 - Tautomero enolico dell'acido 3-indolilpiruvico, suoi sali e usi terapeutici. - Google Patents
Tautomero enolico dell'acido 3-indolilpiruvico, suoi sali e usi terapeutici.Info
- Publication number
- ITRM20020255A1 ITRM20020255A1 IT2002RM000255A ITRM20020255A ITRM20020255A1 IT RM20020255 A1 ITRM20020255 A1 IT RM20020255A1 IT 2002RM000255 A IT2002RM000255 A IT 2002RM000255A IT RM20020255 A ITRM20020255 A IT RM20020255A IT RM20020255 A1 ITRM20020255 A1 IT RM20020255A1
- Authority
- IT
- Italy
- Prior art keywords
- acid
- salts
- indolylpiruvic
- therapeutic uses
- alkali
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
- A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
- C07D209/12—Radicals substituted by oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/08—Indoles; Hydrogenated indoles with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to carbon atoms of the hetero ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
- C07D209/18—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Psychiatry (AREA)
- Epidemiology (AREA)
- Pain & Pain Management (AREA)
- Hospice & Palliative Care (AREA)
- Anesthesiology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Indole Compounds (AREA)
Priority Applications (11)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IT2002RM000255A ITRM20020255A1 (it) | 2002-05-09 | 2002-05-09 | Tautomero enolico dell'acido 3-indolilpiruvico, suoi sali e usi terapeutici. |
JP2004503000A JP2005529146A (ja) | 2002-05-09 | 2003-05-07 | 中枢神経系障害の治療で使用するための実質的に純粋な固形型3−インドリルピルビン酸のエノール互変異性体 |
EP03727938A EP1501503B1 (en) | 2002-05-09 | 2003-05-07 | Substantially pure solid form of the enol tautomer of 3-indolypyruvic acid for use in the treatment of central nervous system disturbances |
CN03810540A CN100588398C (zh) | 2002-05-09 | 2003-05-07 | 用于治疗中枢神经系统紊乱的3-吲哚基丙酮酸的烯醇互变体基本纯的固体形式 |
AU2003233183A AU2003233183A1 (en) | 2002-05-09 | 2003-05-07 | Substantially pure solid form of the enol tautomer of 3-indolylpyruvic acid for use in the treatment of central nervous system disturbances |
CA002483991A CA2483991A1 (en) | 2002-05-09 | 2003-05-07 | Substantially pure solid form of the enol tautomer of 3-indolylpyruvic acid for use in the treatment of central nervous system disturbances |
AT03727938T ATE418334T1 (de) | 2002-05-09 | 2003-05-07 | Enol-tautomer der 3-indol-brenztraubensäure in fester und im wesentlichen reiner form zur behandlung von erkrankungen des zentralen nervensystems |
PCT/IT2003/000275 WO2003094914A1 (en) | 2002-05-09 | 2003-05-07 | Substantially pure solid form of the enol tautomer of 3-indolylpyruvic acid for use in the treatment of central nervous system disturbances |
DE60325468T DE60325468D1 (de) | 2002-05-09 | 2003-05-07 | Enol-tautomer der 3-indol-brenztraubensäure in fester und im wesentlichen reiner form zur behandlung von erkrankungen des zentralen nervensystems |
KR10-2004-7018015A KR20040108787A (ko) | 2002-05-09 | 2003-05-07 | 중추 신경계 장애의 치료에 사용하기 위한 실질적으로순수한 고체 형태의 3-인돌릴피브르산의 에놀 토토머 |
US10/513,859 US20050208125A1 (en) | 2002-05-09 | 2003-05-07 | Substantially pure solid form of the enol tautomer of 3-indolypyruvic acid for use in the treatmetn of central nervous system disturbances |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IT2002RM000255A ITRM20020255A1 (it) | 2002-05-09 | 2002-05-09 | Tautomero enolico dell'acido 3-indolilpiruvico, suoi sali e usi terapeutici. |
Publications (2)
Publication Number | Publication Date |
---|---|
ITRM20020255A0 ITRM20020255A0 (it) | 2002-05-09 |
ITRM20020255A1 true ITRM20020255A1 (it) | 2003-11-10 |
Family
ID=11456293
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IT2002RM000255A ITRM20020255A1 (it) | 2002-05-09 | 2002-05-09 | Tautomero enolico dell'acido 3-indolilpiruvico, suoi sali e usi terapeutici. |
Country Status (11)
Country | Link |
---|---|
US (1) | US20050208125A1 (it) |
EP (1) | EP1501503B1 (it) |
JP (1) | JP2005529146A (it) |
KR (1) | KR20040108787A (it) |
CN (1) | CN100588398C (it) |
AT (1) | ATE418334T1 (it) |
AU (1) | AU2003233183A1 (it) |
CA (1) | CA2483991A1 (it) |
DE (1) | DE60325468D1 (it) |
IT (1) | ITRM20020255A1 (it) |
WO (1) | WO2003094914A1 (it) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2020012373A1 (en) * | 2018-07-10 | 2020-01-16 | Polindols S.R.L.S. | New drugs chronic invalidating pathologies and to slow aging, based on a new metabolic tryptophan route and production process thereof |
WO2021149806A1 (en) * | 2020-01-24 | 2021-07-29 | Morinaga Milk Industry Co., Ltd. | Composition for improving neurite outgrowth |
AU2021329906A1 (en) | 2020-08-18 | 2023-04-27 | Enviro Metals, LLC | Metal refinement |
CN115813919B (zh) * | 2022-12-08 | 2024-02-06 | 佛山市妇幼保健院 | 吲哚-3-丙酮酸或其药用盐在制备治疗乳腺癌药物中的应用 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR1482844A (fr) * | 1964-12-31 | 1967-06-02 | Merck & Co Inc | Procédé de préparation de nouveaux acides 2-[2-(phénylalkyl substitué)-3-indolyl] aliphatiques inférieurs |
FR2306693A1 (fr) * | 1975-04-11 | 1976-11-05 | Roussel Uclaf | Nouveaux derives du /9h/pyrido/3,4-b/ indole et leurs sels, procede de preparation et application a titre de medicaments |
US4822812A (en) * | 1987-05-21 | 1989-04-18 | Merrell Dow Pharmaceuticals Inc. | β-(Fluoromethylene)-5-hydroxytryptophan and derivatives and their use as prodrugs for MAO inhibition |
IT1237472B (it) * | 1989-10-04 | 1993-06-07 | Polifarma Spa | Derivati di acido 3-indolpiruvico, loro procedimento di produzione ed impiego terapeutico. |
TW288010B (it) * | 1992-03-05 | 1996-10-11 | Pfizer |
-
2002
- 2002-05-09 IT IT2002RM000255A patent/ITRM20020255A1/it unknown
-
2003
- 2003-05-07 CN CN03810540A patent/CN100588398C/zh not_active Expired - Fee Related
- 2003-05-07 DE DE60325468T patent/DE60325468D1/de not_active Expired - Lifetime
- 2003-05-07 US US10/513,859 patent/US20050208125A1/en not_active Abandoned
- 2003-05-07 EP EP03727938A patent/EP1501503B1/en not_active Expired - Lifetime
- 2003-05-07 JP JP2004503000A patent/JP2005529146A/ja active Pending
- 2003-05-07 AU AU2003233183A patent/AU2003233183A1/en not_active Abandoned
- 2003-05-07 WO PCT/IT2003/000275 patent/WO2003094914A1/en active Application Filing
- 2003-05-07 KR KR10-2004-7018015A patent/KR20040108787A/ko not_active Application Discontinuation
- 2003-05-07 CA CA002483991A patent/CA2483991A1/en not_active Abandoned
- 2003-05-07 AT AT03727938T patent/ATE418334T1/de not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
CN1652773A (zh) | 2005-08-10 |
AU2003233183A1 (en) | 2003-11-11 |
JP2005529146A (ja) | 2005-09-29 |
ATE418334T1 (de) | 2009-01-15 |
EP1501503B1 (en) | 2008-12-24 |
US20050208125A1 (en) | 2005-09-22 |
ITRM20020255A0 (it) | 2002-05-09 |
CN100588398C (zh) | 2010-02-10 |
EP1501503A1 (en) | 2005-02-02 |
CA2483991A1 (en) | 2003-11-20 |
KR20040108787A (ko) | 2004-12-24 |
WO2003094914A1 (en) | 2003-11-20 |
DE60325468D1 (de) | 2009-02-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NL300933I2 (nl) | Letermovir | |
NO20070249L (no) | Pyrrazolo-pyrimidin derivater | |
BR0308461A (pt) | Derivados de pirimidina | |
BR0308979A (pt) | Derivados de indolilmaleimida | |
UY27181A1 (es) | Derivados de xantina, su preparación y su empleo como medicamentos. | |
WO2003053922A3 (en) | Heteroaryl substituted imidazole modulators of metabotropic glutamate receptor-5 | |
WO2003051833A3 (en) | Heteroaryl substituted pyrazole modulators of metabotropic glutamate receptor-5 | |
UY30025A1 (es) | Derivados sustituidos de las 2-amino-5,6-dihidro pirimidin-4(3h)-onas y sus sales farmacéuticamente aceptables, composiciones farmacéuticas conteniéndolos y aplicaciones. | |
CY1109740T1 (el) | Νεα μεθοδος συνθεσης παραγωγων της 1,3,4,5 -τετραϋδρο-2η- 3-βενζαζεπιν-2-ονης και εφαρμογη στη συνθεση της ιβαβραδινης και των αλατων προσθηκης της σε ενα φαρμακευτικως αποδεκτο οξυ | |
ATE347555T1 (de) | 6-aminomorphinanderivate, herstellungsverfahren dafür und deren verwendung | |
DK1125907T3 (da) | Mellemprodukter til fremstilling af citalopram | |
PA8516901A1 (es) | "5-cloro-3-(4-metansulfonilfenilo)-6'-metil-[2,3'] bipiridinil o en forma cristalina pura y proceso para la síntesis" | |
ES2130161T3 (es) | Procedimiento para la preparacion de ciertos derivados de bifenil-tetrazoles. | |
DK1127886T3 (da) | Syntese af 3,6-dialkyl-5,6-dihydro-4-hydroxy-2H-pyran-2-on | |
ATE496056T1 (de) | Pyrimidinverbindungen mit phosphonatgruppen als antivirale nucleotidanaloga | |
ITRM20020255A1 (it) | Tautomero enolico dell'acido 3-indolilpiruvico, suoi sali e usi terapeutici. | |
BRPI0416678A (pt) | pirazolpirimidinas | |
ATE457972T1 (de) | Verfahren zur herstellung von 7-amino-syn-3,5- dihydroxyheptansäurederivaten und zwischenverbindungen diesesverfahrens und deren herestellung | |
DE602005010369D1 (de) | 2-thiaquinolizidines als Glycosidase- und Glycosyltransferase-Inhibitoren | |
NO20010265D0 (no) | 3-(1-hydroksy-pentyliden)-5-nitro-3H-benzofuran-2-on, fremgangsmåte for fremstilling og anvendelse derav | |
ITMI20020933A1 (it) | Procedimento per la sintesi di clopidogrel | |
DE602004025935D1 (de) | Histondeacetylaseinhibitor und verfahren zu dessen herstellung | |
ATE411299T1 (de) | Chlorsubstituierte guanidine | |
BR9907876A (pt) | Processos e intermediários úteis para produção de antifolatos | |
DE60009032T2 (de) | Benzolsulfonamid-derivate und ihre verwendung |